187 related articles for article (PubMed ID: 38566120)
1. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F; Haneke H; Efe IE; Kuhrt LD; Motta E; Nickl B; Flüh C; Synowitz M; Dzaye O; Bader M; Kettenmann H
Acta Neuropathol Commun; 2024 Apr; 12(1):50. PubMed ID: 38566120
[TBL] [Abstract][Full Text] [Related]
2. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na
Ono Y; Chiba S; Yano H; Nakayama N; Saio M; Tsuruma K; Shimazawa M; Iwama T; Hara H
Biochem Biophys Res Commun; 2016 Dec; 481(1-2):7-12. PubMed ID: 27836549
[TBL] [Abstract][Full Text] [Related]
5. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
[TBL] [Abstract][Full Text] [Related]
6. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
7. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.
Zhu C; Mustafa D; Zheng PP; van der Weiden M; Sacchetti A; Brandt M; Chrifi I; Tempel D; Leenen PJM; Duncker DJ; Cheng C; Kros JM
Neuro Oncol; 2017 May; 19(5):648-659. PubMed ID: 28453746
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
9. SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.
Kaminska P; Ovesen PL; Jakiel M; Obrebski T; Schmidt V; Draminski M; Bilska AG; Bieniek M; Anink J; Paterczyk B; Jensen AMG; Piatek S; Andersen OM; Aronica E; Willnow TE; Kaminska B; Dabrowski MJ; Malik AR
EMBO Rep; 2024 May; 25(5):2278-2305. PubMed ID: 38499808
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
11. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
[TBL] [Abstract][Full Text] [Related]
12. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
De Boeck A; Ahn BY; D'Mello C; Lun X; Menon SV; Alshehri MM; Szulzewsky F; Shen Y; Khan L; Dang NH; Reichardt E; Goring KA; King J; Grisdale CJ; Grinshtein N; Hambardzumyan D; Reilly KM; Blough MD; Cairncross JG; Yong VW; Marra MA; Jones SJM; Kaplan DR; McCoy KD; Holland EC; Bose P; Chan JA; Robbins SM; Senger DL
Nat Commun; 2020 Oct; 11(1):4997. PubMed ID: 33020472
[TBL] [Abstract][Full Text] [Related]
13. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
Brandenburg S; Müller A; Turkowski K; Radev YT; Rot S; Schmidt C; Bungert AD; Acker G; Schorr A; Hippe A; Miller K; Heppner FL; Homey B; Vajkoczy P
Acta Neuropathol; 2016 Mar; 131(3):365-78. PubMed ID: 26718201
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated CD204
Sørensen MD; Kristensen BW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
[TBL] [Abstract][Full Text] [Related]
15. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
16. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
Front Immunol; 2018; 9():2750. PubMed ID: 30542347
[TBL] [Abstract][Full Text] [Related]
17. Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling.
Hu F; Dzaye O; Hahn A; Yu Y; Scavetta RJ; Dittmar G; Kaczmarek AK; Dunning KR; Ricciardelli C; Rinnenthal JL; Heppner FL; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
Neuro Oncol; 2015 Feb; 17(2):200-10. PubMed ID: 25452390
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR
Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087
[TBL] [Abstract][Full Text] [Related]
19. Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
Brandenburg S; Blank A; Bungert AD; Vajkoczy P
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375505
[TBL] [Abstract][Full Text] [Related]
20. CDYL knockdown reduces glioma development through an antitumor immune response in the tumor microenvironment.
Kong JG; Mei Z; Zhang Y; Xu LZ; Zhang J; Wang Y
Cancer Lett; 2023 Jul; 567():216265. PubMed ID: 37302564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]